US mesothelioma patterns 1973–2002: indicators of change and insights into background rates
暂无分享,去创建一个
[1] E. Lau,et al. Therapeutic radiation for lymphoma , 2007, Cancer.
[2] C. Cardinez,et al. United States cancer statistics; 2003 incidence and mortality , 2006 .
[3] A. Oshima,et al. Incidence and survival of mesothelioma in Osaka, Japan. , 2006, Japanese journal of clinical oncology.
[4] V. Rusch,et al. Malignant mesothelioma in Australia , 2006 .
[5] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[6] Ken Takahashi,et al. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. , 2006, American journal of industrial medicine.
[7] Denis H. Rushworth. The Navy and Asbestos Thermal Insulation , 2005 .
[8] M. Price,et al. Mesothelioma mortality in Great Britain from 1968 to 2001. , 2005, Occupational medicine.
[9] A. Churg,et al. Changing trends in US mesothelioma incidence , 2004, Occupational and Environmental Medicine.
[10] Bertram Price,et al. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. , 2004, American journal of epidemiology.
[11] A. Polednak. Geographic distribution of incident mesothelioma in Connecticut men, 1990–99 , 2003, International journal of cancer.
[12] A. Andersen,et al. Incidence trends of mesothelioma in Norway, 1965–1999 , 2003, International journal of cancer.
[13] Manfred Neuberger,et al. Three decades of pleural cancer and mesothelioma registration in Austria where asbestos cement was invented , 2003, International archives of occupational and environmental health.
[14] Michael Huncharek,et al. Non-asbestos related diffuse malignant mesothelioma. , 2002, Tumori.
[15] J. Leigh,et al. Malignant mesothelioma in Australia, 1945-2000. , 2002, American journal of industrial medicine.
[16] K. McPherson,et al. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[17] C. la Vecchia,et al. An age, period and cohort analysis of pleural cancer mortality in Europe. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[18] B. Hankey,et al. The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] G. Hillerdal. Mesothelioma: cases associated with non-occupational and low dose exposures. , 1999, Occupational and environmental medicine.
[20] F Levi,et al. The European mesothelioma epidemic , 1999, British Journal of Cancer.
[21] C. Bianchi,et al. Latency periods in asbestos-related mesothelioma of the pleura. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[22] B. Price. Analysis of current trends in United States mesothelioma incidence. , 1997, American journal of epidemiology.
[23] J. Benichou,et al. Malignant mesothelioma: attributable risk of asbestos exposure. , 1994, Occupational and environmental medicine.
[24] M. Jaurand,et al. The Mesothelial Cell and Mesothelioma , 1994 .
[25] B. Lanphear,et al. Latent period for malignant mesothelioma of occupational origin. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[26] J. Wagner,et al. Background incidence of mesothelioma: animal and human evidence. , 1991, Regulatory toxicology and pharmacology : RTP.
[27] J M Peters,et al. Recent trends in mesothelioma incidence in the United States. , 1986, American journal of industrial medicine.
[28] J. Mcdonald,et al. Health implications of environmental exposure to asbestos. , 1985, Environmental health perspectives.
[29] A. Musk,et al. Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia , 1985, The Medical journal of Australia.
[30] A. D. McDonald,et al. Mesothelioma and asbestos fibre type. , 1985, British journal of industrial medicine.
[31] W. Rom,et al. TRENDS IN MORTALITY OF DIFFUSE MALIGNANT MESOTHELIOMA OF PLEURA , 1983, The Lancet.
[32] N. Dreyer,et al. Projections of asbestos-related disease 1980-2009. , 1983, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[33] K. Rothman,et al. Epidemiologic Analysis with a Programmable Calculator , 1982 .
[34] I. Selikoff,et al. Occupational exposure to asbestos: population at risk and projected mortality--1980-2030. , 1982, American journal of industrial medicine.
[35] A. D. McDonald,et al. Malignant mesothelioma in North America , 1980, Cancer.
[36] J. Fraumeni,et al. Cancer mortality in U.S. counties with shipyard industries during World War II. , 1979, Environmental research.
[37] R. Doll. Cancer in Five Continents , 1972, Proceedings of the Royal Society of Medicine.
[38] A. Berger. FUNDAMENTALS OF BIOSTATISTICS , 1969 .
[39] T. Miller. Late results in peptic ulcer. , 1947, The American journal of medicine.
[40] F. J. Viles,et al. A health survey of pipe covering operations in constructing naval vessels. , 1946, The Journal of industrial hygiene and toxicology.